Immunological physiopathology of cutaneous adverse drug reactions

European Journal of Dermatology

Volumn 7, Issue 5, 1997, Pages 319-323

  Barbaud, Annick ^a   Béné, Marie Christine ^b   Faure, Gilbert ^b  

^a SERVICE DE DERMATOLOGIE   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Betalactam antibiotics; Cutaneous adverse drug reaction; Erythema multiforme; Fixed drug eruption; Hypersensitivity; Maculo papular rash; Urticaria

Indexed keywords

BETA LACTAM ANTIBIOTIC; CD4 ANTIGEN; CD8 ANTIGEN; EPITOPE; GAMMA INTERFERON; HLA ANTIGEN; IMMUNOGLOBULIN E; TUMOR NECROSIS FACTOR ALPHA;

ANGIONEUROTIC EDEMA; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; BULLOUS SKIN DISEASE; DRUG ERUPTION; ERYTHEMA MULTIFORME; HUMAN; KERATINOCYTE; LICHENOID ERUPTION; RASH; REVIEW; SKIN ALLERGY; STEVENS JOHNSON SYNDROME; T LYMPHOCYTE ACTIVATION; TOXIC EPIDERMAL NECROLYSIS; URTICARIA;

EID: 0030796913     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Tone T, Nishioka K, Kameyama K, Asai T, Takezaki S, Nishiyama S. Common histopathological processes of phenytoin drug eruption. J Dermatol 1992; 19: 27-34.
2. Bircher A, Hunziker N. Facteurs de risques dans l'allergie médicamenteuse. In: Progrès en Dermato-Allergologie. Médiscript ed, Viternes F, 1995; 77-885.
3. Chosidow O, Bourgault I, Roujeau J-C. Drug rashes. What are the targets of cell-mediated cytotoxicity? Arch Dermatol 1994; 130: 627-9.
4. De Weck AL. Pharmacologic and immunochemical mechanisms of drug hypersensitivity. Immunol All Clin North Am 1991; 11: 461-74.
5. + T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J Immunol 1995; 155: 462-72.
6. Hertl M, Merck HF. Lymphocyte activation in cutaneous drug reactions. J Invest Dermatol 1995; 105: 95s-8s.
7. Koponen M, Pichler WJ, de Weck AL. T cell reactivity to penicillin: phenotypic analysis of in vitro activated cell subsets. J Allergy Clin Immunol 1986; 78: 645-52.
8. Barbaud A. Place of excipients in drug-related allergy. Clin Rev Allergol Immunol 1995; 13: 253-63.
9. Popescu NA, Sheehan MG, Kuides PA, Loughner JE, Condemi JJ, Looney RJ, Leddy JP. Allergic reactions to cyclophosphamide: delayed clinical expression associated with positive immediate skin tests to drug metabolites in five patients. J Allergy Clin Immunol 1996; 97: 26-33.
10. Blanca M, Vega JM, Garcia J, Carmona MJ, Terado S, Avila MJ, Miranda A, Juarez C. New aspects of allergic reactions to betalactams: cross reactions and unique specificities. Clin Exp Allergy 1994; 24: 407-15.
11. Romano A, Di Fonso M, Papa G, Pietrantonio F, Federico F, Fabrizi G, Venuti A. Evaluation of adverse cutaneous reactions to amino penicillins with emphasis on those manifested by maculopapular rashes. Allergy 1995; 50: 113-8.
12. Adkinson NF. Side chain specific beta-lactam allergy. Clin Exp Allergy 1990; 20: 445-7.
13. Silviu-Dan F, McPhillips S, Warrington RJ. The frequency of skin test reactions to side-chain penicillin determinants. J Allergy Clin Immunol 1993; 91: 694-701.
14. Vega J, Blanca MM, Carmona MJ, Claras A, Juarez C, Moya MC. Immediate allergic reactions to amoxicillin. Allergy 1994; 49: 317-22.
15. Voorhorst R, Sparreboom S. The use of stereoisomers in patch testing. Ann Allergy 1980; 45: 100-3.
16. Bell SJD, Pichler WJ. Penicillin-allergic patients react to penicillin-modified "self". Allergy 1989; 44: 199-203.
17. Brander C, Mauri-Hellweg D, Bettens F, Rolli H, Goldman M, Pichler WJ. Heterogeneous T cell responses to beta-lactam-modified self-sructures are observed in penicillin-allergic individuals. J Immunol 1995; 155: 2670-8.
18. + T cell clones from the peripheral blood of patients with cutaneous reaction to beta-lactam antibiotics. Br J Dermatol 1993; 128: 619-26.
19. Mobini N, Ahmed AR. Immunogenetics of drug-induced bullous diseases. Clin Dermatol 1993; 11: 449-60.
20. + T lymphocytes in bullous cutaneous reactions caused by B-lactam antibiotics. J Invest Dermatol 1993; 101: 794-9.
21. Barbaud A, Béné MC, Schmutz JL, Ehlinger A, Weber M, Faure GC. Role of delayed cellular hypersensitivity and adhesion molecules in amoxicillin-induced morbilliform rashes. Arch Dermatol 1997; 133: 481-6.
22. Warrington R, Silviu-Dan F, Magro C. Accelerated cell-mediated immune reactions in penicillin allergy. J Allergy Clin Immunol 1993; 92: 626-8.
23. Miyauchi H, Hosokawa H, Akaeda T, Iba H, Asada Y. T cell subsets in drug-induced toxic epidermal necrolysis. Possible pathogenic mechanism induced by CD8-positive T cells. Arch Dermatol 1991; 127: 851-5.
24. Villada G, Roujeau JC, Clerici T, Bourgault I, Revuz J. Immunopathology of toxic epidermal necrolysis. Keratinocytes, HLA-DR expression, Langerhans cells, and mononuclear cells: an immunopathologic study of five cases. Arch Dermatol 1992; 128: 50-3.
25. Perez T, Girard JP, Dayer E. Imbalance of CD45R and CDw29 helper cell subsets after seven days of culture from penicillin hypersensitive patients. Allergy 1991; 46: 379-85.
26. Tagami H, Tatsuta K, Iwatski K, Yamada M. Delayed hypersensitivity in ampicillin-induced toxic epidermal necrolysis. Arch Dermatol 1983; 119: 910-3.
27. Roujeau JC, Dubertret L, Moritz S, Jouault H, Heslan M, Revuz J, Touraine R. Involvement of macrophages in the pathology of toxic epidermal necrolysis. Br J Dermatol 1985; 113: 425-30.
28. Hagdrup H, Tonnesen E, Clemmensen O, Andersen KE. Abnormalities of lymphocyte function and phenotypic pattern in a case of toxic epidermal necrolysis. Acta Derm Venereol 1992; 72: 268-70.
29. Hertl M, Merk HF, Bohlen H. T cell subsets in drug-induced toxic epidermal necrolysis. Arch Dermatol 1992; 128: 272-3.
30. Friedmann PS, Strickland I, Pirmohamed M, Park K. Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine. Arch Dermatol 1994; 130: 598-604.
31. Paquet P, Nikkels A, Arrese JE, Vanderkelen A, Pierard GE. Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis. Arch Dermatol 1994; 130: 605-8.
32. Moncada B, Delgado C, Quevado MA. Abnormal T cell response in toxic epidermal necrolysis. Arch Dermatol 1994; 130: 116.
33. Wolkenstein P, Chosidow O, Flechet ML, Robbiola O, Paul M, Dumé L, Revuz J, Roujeau JC. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis 1996; 35: 234-6.
34. Heng MCY, Allen SG. Efficacy of cyclophosphamide in toxic epidermal necrolysis. Clinical and pathophysiologic aspects. J Am Acad Dermatol 1991; 25: 778-86.
35. Rasmussen JE. Erythema multiforme. Should anyone care about the standards of care? Arch Dermatol 1995; 131: 726-9.
36. Paul C, Wolkenstein P, Adle H, Wechsler J, Garchon HJ, Revuz J, Roujeau JC. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol 1996; 134: 710-4.
37. Bruynzeel DP, Von Blomberg-Van der Flier RJ, Scheper RJ, Van Ketel WG, de Haan P. Penicillin allergy and the relevance of epicutaneous tests. Dermatologica 1985; 171: 429-34.
38. Bruynzeel DP, Van Ketel WG. Skin tests in the diagnosis of morbilliform drug eruptions. Semin Dermatol 1987; 6: 119-24.
39. Dascalu DI, Kletter Y, Baratz M, Brenner S. Langerhans' cell distribution in drug eruption. Acta Derm Venereol 1992; 72: 175-7.
40. Visa K, Kayhko K, Stubb S, Reitamo S. Immunocompetent cells of fixed drug eruption. Acto Derm Venereol 1987; 67: 30-5.
41. Hindsen M, Christensen OB, Gruic V, Lofberg H. Fixed drug eruption: an immunohistochemical investigation of the acute and healing phase. Br J Dermatol 1987; 116: 351-60.
42. Shiohara T, Nickoloff BJ, Sagawa Y, Gomi T, Nagashima M. Fixed drug eruption. Expression of epidermal keratinocyte intercellular adhesion molecule-1 (ICAM-I). Arch Dermatol 1989; 125: 1371-6.
43. Smoller BR, Luster AD, Krane JF, Krueger J, Gray MH, McNutt NS, Hsu A, Gottlieb AB. Fixed drug eruptions: evidence for a cytokine-mediated process. J Cutan Pathol 1991; 18: 13-9.
44. Teraki Y, Moriya N, Shiohara T. Drug-induced expression of intercellular adhesion molecule-1 on lesional keratinocytes in Fixed drug eruption. Am J Pathol 1994; 145: 550-60.
45. Komatsu T, Moriya N, Shiohara T. T cell receptor (TCR) repertoire and function of human epidermal T cells: restricted TCR V alpha-V beta genes are utilized by T cells residing in the lesional epidermis in fixed drug eruption. Clin Exp Immunol 1996; 104: 343-50.
46. Bretin N, Dreno B, Bureau B, Litoux P. Immunohistological study of captopril-induced late cutaneous eruptions. Dermatologica 1988; 177: 11-5.
47. Osawa J, Kitamura K, Saito S, Ikezawa Z, Nakajima H. Immunohistochemical study of graft-versus-host. Reaction (GVHR)-type drug eruptions. J Dermatol 1994; 21: 25-30.